Cannabinoid receptors expression testing (CBR)

Siniscalco et al. (J Autism Dev Disord. 2013; J Neuroinflammation 2014) reported that Cannabinoid receptor type 2 is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders and proposed CBR2 receptor as potential therapeutic target for the pharmacological management of the autism.
CBR: Request Form from EU
CBR: Request Form from USA
RNA-based tests : One TempusTM tube. Stable for 72 hours at ambient temperature. For longer periods freeze and ship at -20°C